Relay Therapeutics, Inc. (RLAY) KPIs and segments

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30

$18.09+0.01 (+0.06%)

Close on Nov 13, 2026Market cap $3.96BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Relay Therapeutics's business

Coming soon

This tab will track the numbers specific to Relay Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?